Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models-Reference-Cited by-同舟云学术

Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models

Published:2018-03-21 Issue:3 Volume:138 Page:489-498
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Keir Stephen T.^ORCID,Chandramohan Vidyalakshmi,Hemphill Carlee D.,Grandal Michael M.,Melander Maria Carlsen,Pedersen Mikkel W.,Horak Ivan D.,Kragh Michael,Desjardins Annick,Friedman Henry S.,Bigner Darell D.

Funder

Symphogen A/S

Merck KGaA

Tisch Preclinical Therapy Screening Program

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/article/10.1007/s11060-018-2832-6/fulltext.html

Reference47 articles.

1. Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64:479–489

2. Wen PY, Kesari S (2008) Malignant gliomas in adults. New Eng J Med 359(5):492–507

3. Delgado-Lopez PD, Corrales-Garcia EM (2016) Survival in glioblastoma: a review on the impact of treatment modalities. Clin Transl Oncol 18(11):1062–1071

4. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New Eng J Med 352(10):987–996

5. Stupp R, van den Bent MJ, Hegi ME (2005) Optimal role of temozolomide in the treatment of malignant gliomas. Curr Neurol Neurosci Rep 5(3):198–206

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving the efficacy of anti-EGFR drugs in GBM: Where we are going?;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

2. Role of Endocytosis Proteins in Gefitinib-Mediated EGFR Internalisation in Glioma Cells;Cells;2021-11-21

3. Novel facets of glioma invasion;Actin Cytoskeleton in Cancer Progression and Metastasis – Part C;2021

4. Practical Bioinformatic DNA-Sequencing Pipeline for Detecting Oncogene Amplification and EGFRvIII Mutational Status in Clinical Glioblastoma Samples;The Journal of Molecular Diagnostics;2019-05

5. Development and validation of a (RP)UHPLC-UV-(HESI/Orbitrap)MS method for the identification and quantification of mixtures of intact therapeutical monoclonal antibodies using a monolithic column;Journal of Pharmaceutical and Biomedical Analysis;2018-09